753 related articles for article (PubMed ID: 22665688)
1. Alzheimer's disease: early diagnosis and treatment.
Chu LW
Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
Cummings JL
Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease biomarkers.
Chiu HF; Li SW
Hong Kong Med J; 2012 Aug; 18(4):351-2; author reply 352. PubMed ID: 22865186
[No Abstract] [Full Text] [Related]
6. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment of dementia.
Schwarz S; Froelich L; Burns A
Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
[TBL] [Abstract][Full Text] [Related]
8. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
9. [Is there a treatment for Alzheimer's disease?].
Joray S; Ghika J; von Gunten A; Büla C; Gold G; Assal F
Rev Med Suisse; 2005 May; 1(18):1201-2, 1205-6, 1208. PubMed ID: 15977708
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
11. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.
Schneider LS; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M
J Intern Med; 2014 Mar; 275(3):251-83. PubMed ID: 24605808
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study.
Matsuzono K; Hishikawa N; Ohta Y; Yamashita T; Deguchi K; Nakano Y; Abe K
J Alzheimers Dis; 2015; 45(3):771-80. PubMed ID: 25624417
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
Popp J; Arlt S
Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Alzheimer's disease: current status and new perspectives.
Scarpini E; Scheltens P; Feldman H
Lancet Neurol; 2003 Sep; 2(9):539-47. PubMed ID: 12941576
[TBL] [Abstract][Full Text] [Related]
17. Memantine: a review of its use in Alzheimer's disease.
Robinson DM; Keating GM
Drugs; 2006; 66(11):1515-34. PubMed ID: 16906789
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
[TBL] [Abstract][Full Text] [Related]
19. Memantine for treatment of moderate to severe Alzheimer's disease.
Perras C
Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
Riordan KC; Hoffman Snyder CR; Wellik KE; Caselli RJ; Wingerchuk DM; Demaerschalk BM
Neurologist; 2011 Mar; 17(2):121-3. PubMed ID: 21364371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
